Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Global cancer survival rates improve, but wide gaps remain

Cancer patients’ survival prospects are improving – even for some of the deadliest types such as lung cancer – but there are huge disparities between countries, particularly for children, according to a published study.

Read More »

Health investors roll out unwelcome mat for Amazon’s arrival

Investors for months have fretted over a potential Amazon entry into healthcare delivery, particularly selling prescription drugs.

Read More »

Shire Snaps Up Rights to Preclinical Autoimmune Candidate for Undisclosed Sum

Rare disease giant Shire plc purchased a preclinical autoimmune drug candidate being developed by AB Biosciences.

Read More »

BridgeBio Launches QED Therapeutics With $65 Million, Abandoned Novartis Cancer Program

Palo Alto, Calif.-based BridgeBio Pharma is launching a new spinout to develop a recently abandoned Novartis cancer treatment now in its possession.

Read More »

FDA asks drugmakers to limit amount of opioid drug in packaging

The U.S. Food and Drug Administration is asking manufacturers of a common opioid medicine to change the way the drug is packaged, as part of efforts to deter its abuse amid an opioid epidemic in the United States.

Read More »

Pfizer Confirms Neuroscience Cuts, Shelves Another Four Early-Stage Projects

Pfizer released an update of the company’s pipeline, including eight different discontinued projects in the field of neuroscience.

Read More »

Eisai and Boston University School of Medicine Announce Research Collaboration to Study the Effects of Alzheimer’s Disease-associated Genetic Variants on Brain

Eisai Inc. and Boston University School of Medicine have formed a research collaboration to study the effects of Alzheimer’s disease-associated genetic variants on the behavior of brain cells, called microglia.

Read More »

Amazon, Berkshire, JPMorgan create healthcare company to cut costs Inc., Berkshire Hathaway and JPMorgan Chase & Co. will form a healthcare company aimed at cutting costs for their U.S. employees, they said on Tuesday, sending shares in the broad healthcare sector sharply lower.

Read More »

Corbus CF drug to get FDA review on flare-up data

Corbus Pharmaceuticals Holdings Inc said the U.S. Food and Drug Administration will evaluate its experimental cystic fibrosis drug without requiring proof the product improves lung function.

Read More »

FDA Grants Breakthrough Therapy Designation To Roche’s Autism Drug

An experimental Roche drug designed to improve social interaction in people with autism scored the U.S. Food and Drug Administration’s Breakthrough Therapy Designation.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom